Worldwide Interventional Spine Devices Market (2020 to 2024) - Featuring Alphatec Holdings, Globus Medical & Integra LifeSciences Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Interventional Spine Devices Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The interventional spine devices market is poised to grow by $ 2.31 bn during 2020-2024 progressing at a CAGR of 10% during the forecast period.

The report on the interventional spine devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing number of incidences of spine and bone disorders and favourable reimbursement scenario. In addition, increasing number of incidences of spine and bone disorders is anticipated to boost the growth of the market as well.

The interventional spine devices market analysis includes procedure segment and geographic landscapes. This study identifies the growing demand for MI and non-invasive procedures as one of the prime reasons driving the interventional spine devices market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The interventional spine devices market covers the following areas:

• Interventional spine devices market sizing
• Interventional spine devices market forecast
• Interventional spine devices market industry analysis

Companies Mentioned

• Abbott Laboratories
• Alphatec Holdings Inc.
• Globus Medical Inc.
• Integra LifeSciences Corp.
• Johnson & Johnson
• Medtronic Plc
• Nuvasive Inc.
• RTI Surgical Holdings Inc.
• Stryker Corp.
• Zimmer Biomet Holdings Inc.

Key Topics Covered:

1. Executive Summary

• Market Overview

2. Market Landscape

• Market ecosystem
• Value chain analysis

3. Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 - 2024

4. Five Forces Analysis

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

5. Market Segmentation by Other1

• Market segments
• Comparison by Other1
• Vertebroblasty - Market size and forecast 2019-2024
• Kyphoplasty - Market size and forecast 2019-2024
• Radiofrequency ablation - Market size and forecast 2019-2024
• Others - Market size and forecast 2019-2024
• Market opportunity by Other1

6. Customer landscape

• Overview

7. Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• APAC - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography

8. Drivers, Challenges, and Trends

• Market drivers
• Volume driver - Demand led growth
• Volume driver - Supply led growth
• Volume driver - External factors
• Volume driver - Demand shift in adjacent markets
• Price driver - Inflation
• Price driver - Shift from lower to higher priced units
• Market challenges
• Market trends

9. Vendor Landscape

• Overview
• Landscape disruption

10. Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Abbott Laboratories
• Alphatec Holdings Inc.
• Globus Medical Inc.
• Integra LifeSciences Corp.
• Johnson & Johnson
• Medtronic Plc
• Nuvasive Inc.
• RTI Surgical Holdings Inc.
• Stryker Corp.
• Zimmer Biomet Holdings Inc.

11. Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/ko3yb7